Abstract
Background and importanceAdalimumab and etanercept are two of the most used biologic drugs worldwide in a variety of chronic diseases. The introduction of biosimilar drugs (BS) for both has revolutionised...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have